Adding the novel cancer drug Erbitux to standard chemotherapy helped advanced lung cancer patients live just a month longer than chemo alone, a study found. Although this is the first study to find a survival benefit from a newer, more targeted …

Originally Syndicated via RSS from vioxx - Live Search News